Join
Live feed
·
INSIDERFilingvia Quantisnow
Olema Pharmaceuticals Inc. logo

Director Harmon Cyrus sold $61,300 worth of shares (5,000 units at $12.26), decreasing direct ownership by 0.66% to 756,283 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
OLMA· Olema Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track OLMA (Olema Pharmaceuticals Inc.) and more on Quantisnow.